siRNA treatment decreases triglycerides in clients along with rare condition

.ANALYSIS FEATURE.19 September 2024.

Plozasiran decreased triglyceride amounts by 80% as well as reduced the risk of pancreatitis in clients along with consistent chylomicronemia, along with or even without a hereditary medical diagnosis.